Skip to content

Incremental Cost-Utility Study on Prehabilitation Among Older Patients With Colorectal Cancer Undergoing Surgery

Incremental Cost-utility Study on Prehabilitation for Colon Cancer Surgery in Older Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04097795
Acronym
PreColo CU
Enrollment
72
Registered
2019-09-20
Start date
2019-07-01
Completion date
2021-12-31
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Surgery

Brief summary

A prospective multicenter observational cost-utility study following older or high-risk patients with colorectal cancer with and without prehabilitation before surgery.

Detailed description

This study will answer the question whether prehabilitation is cost-effective in colorectal cancer surgery among individual patients aged 70 years and above or patients with an American Society of Anesthesiologists (ASA) score of III. We also aim to identify factors facilitating or impairing implementation of prehabilitation such that it is cost-effective.

Interventions

OTHERPrehabilitation

According to our definition, prehabilitation consists of exercise therapy during at least 2 weeks. This is combined with optimalisation of the patients' nutritional status at least 2 weeks before surgery.

Sponsors

Leading the Change: Collaboration of health Insurers in the Netherlands
CollaboratorUNKNOWN
Radboud University Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Age ≥ 70 years or American Society of Anesthesiologists (ASA) score of III * Scheduled for colorectal cancer surgery

Exclusion criteria

* Metastatic disease known preoperatively * ASA IV score or higher * Paralytic or immobilized patients (not capable to perform exercise) * Prior use of neoadjuvant therapy for the same indication * Not able or willing to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
EQ-5D-5L0-6 monthsQuality of life according to the EuroQol-5 dimensions-5 levels questionnaire. The 5 dimensions cover mobility, selfcare, daily activities, pain/discomfort and anxiety. All dimensions are rated on a 5 level scale ranging from 'I have no problems with ....(dimension)' to 'I am not able to/I am extremely...(dimension)'. The first option is considered 'better' and the latter as 'worse'.
Costs0-6 monthsFrom a societal perspective including health care consumption costs, patient out-of-pocket costs, and productivity losses of informal caregivers

Secondary

MeasureTime frameDescription
(I)ADL dependence by GARS0-6 monthsDependence regarding (instrumental) acitivities of daily living ((I)ADL)according to the Gait Assessment Rating Scale (GARS). Several items with regard to self-reliance are scored according to the phrase 'I can do ....(item) completely independently.......'. Possible answers are 'Without any effort', 'with some effort', 'With a lot of effort', and 'Only with help from others'. The first is considered better and the latter as worse.
(I)ADL dependence by TOPICS-SF0-6 monthsDependence regarding (instrumental) acitivities of daily living according toThe Older Persons and Informal Caregivers Survey Short form (TOPICS-SF) questionnaire for patients. This questionnaire contains GARS and EQ-5D amongst others and is spread throughout the questionnaire.
Number of deceased patients0-6 monthsData on mortality will be assessed based on medical records.
Care-related burden among informal caregivers0-6 monthsThe Older Persons and Informal Caregivers Survey Minimum Dataset (TOPICS-MDS) questionnaire for caregivers in which the domains 'self-reported health' (by RAND-36 health survey), 'quality of life' (by carerQol), 'hours of informal care' (number), and 'perceived burden' (on visual analog scale) are covered.
Return to normal activity0-6 monthsThe return to normal activity (RNA) of patients is investigated by the different questionnaires listed above on several time-points. After surgery, we can examine the time within a time frame of 6 months that patients return to their normal activities.
Morbidity0-6 monthsNumber and severity of complications will be assed based on medical records.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026